HCW BIOLOGICS INC. - C
0,4200
07-октября-24 14:59:31
15 мин. задержка
Акции
-0,0305
-6,77%
Сегодняшний диапазон
0,4200 - 0,5100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
03 авг 2022 06:15:00 Источник Nasdaq GlobeNewswire
-
23 май 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
13 май 2022 06:15:00 Источник Nasdaq GlobeNewswire
-
05 май 2022 06:30:01 Источник Nasdaq GlobeNewswire
-
19 апр 2022 06:33:00 Источник Nasdaq GlobeNewswire
-
28 мар 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
24 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
24 янв 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
20 янв 2022 07:00:03 Источник Nasdaq GlobeNewswire
-
19 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 – 13, 2022
06 янв 2022 06:33:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year
13 дек 2021 06:31:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
12 ноя 2021 06:00:02 Источник Nasdaq GlobeNewswire
-
28 окт 2021 06:00:01 Источник Nasdaq GlobeNewswire
-
24 авг 2021 06:32:00 Источник Nasdaq GlobeNewswire
-
17 авг 2021 06:32:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
13 авг 2021 06:10:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
22 июл 2021 15:05:00 Источник Nasdaq GlobeNewswire
-
HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering
19 июл 2021 17:39:57 Источник Nasdaq GlobeNewswire